​

To support COVID-19 research, BioTimes, Inc. has developed antibodies against different antigens of SARS-CoV-2. These antibodies can be used in diagnostic solutions to detect the virus in immunoassays including lateral flow devices, ELISA, Western blot, immunofluorescent staining, immunohistochemistry, multiplex assay systems, or to neutralize the virus potentially in vivo studies. The human antibodies can be used as direct positive controls in diagnostic products.

​

​

We like to hear from you, please contact us here if there is any product you cannot find in our collection.